Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 4 Thoracic 2 Other solid neoplasm 1 Gynecologic 1 Gastrointestinal 1 Breast 1

Conditions

Pancreatic Neoplasms 1

Interventions

Gemcitabine 217 Fluorouracil 141 Oxaliplatin 131 Capecitabine 122 pembrolizumab 113 Irinotecan 109 Leucovorin 103 Bevacizumab 98 Nivolumab 80 130-nm albumin-bound paclitaxel 80 Cisplatin 79 Cetuximab 79 Radiotherapy 78 Albumin-Bound Paclitaxel 59 Sorafenib 56 Paclitaxel 53 Cyclophosphamide 49 Carboplatin 47 Magnetic Resonance Spectroscopy 43 Specimen Handling 39 Docetaxel 37 Taxes 36 Radiation 34 fludarabine 33 Ipilimumab 33 Erlotinib Hydrochloride 33 durvalumab 32 Biopsy 32 Folfox protocol 28 Radiosurgery 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Valacyclovir × Gastrointestinal × Clear all

NCT00638612 2023-08-25

PaTK01

Candel Therapeutics, Inc.

Phase 1 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡